(lp0
S"Galena Biopharma, Inc.  Shares on the Rise Amid Positive Clinical Trial Data Smarter Analyst - Mar 17, 2017 Galena Biopharma Inc  investors have a smile on their faces Friday morning, after the drug maker announced positive data from the Company's GALE-301  investigator-sponsored Phase 1/2a clinical trial."
p1
aS'Galena Biopharma Inc.  Moves Higher on Volume Spike for March 17 Equities.com - 17 hours ago Galena Biopharma Inc.  traded on unusually high volume on Mar. 17, as the stock gained 0.85% to close at $0.63. On the day, Galena Biopharma Inc. saw 14.46 million shares trade hands on 17,901 trades. Considering that the stock averages only a&nbsp;...Stock Update : Galena Biopharma Inc Announces 4Q and Year End ... - Smarter AnalystGalena Biopharma, Inc.  Quarterly EPS At $-0.23 - Stock Observer'
p2
aS'Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against ... Yahoo Finance - 20 hours ago NEW YORK, NY / ACCESSWIRE / March 17, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of Galena Biopharma, Inc.  investors who purchased Galena stock between August 11, 2014 and January 31, 2017, inclusive (the&nbsp;...'
p3
aS'GALE STOCK LOSS: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of ... GlobeNewswire  - 17 hours ago NEW YORK, March 17, 2017  -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities  from August 11, 2014 through January 31, 2017, both dates inclusive (the&nbsp;...'
p4
aS'Galena Biopharma Inc  Hires Canaccord Genuity to Advise on Strategic ... Smarter Analyst - Mar 9, 2017 Galena Biopharma Inc  announced it has engaged Canaccord Genuity, Inc. as its financial advisor to assist in the previously announced strategic alternative review process.Most Active Stock: Galena Biopharma, Inc.  - HugoPressThe Galena Biopharma, Inc.  Given Consensus Recommendation of Hold by ... - DailyQuint'
p5
aS'GALENA BIOPHARMA, INC.  Files An 8-K Departure of Directors or ... Market Exclusive - Mar 14, 2017 Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs.'
p6
aS'IMPORTANT GALENA BIOPHARMA, INC. INVESTOR ALERT: Wolf Haldenstein Adler ... GlobeNewswire  - Feb 24, 2017 NEW YORK, Feb. 24, 2017  -- Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a federal securities class action has been filed in the United States District Court for the District of New Jersey against Galena Biopharma, Inc.'
p7
aS"Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim ... GlobeNewswire  - Feb 21, 2017 SAN RAMON, Calif., Feb. 21, 2017  -- Galena Biopharma, Inc. , a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced that the Company's&nbsp;...Investor Alert: Kaplan Fox Announces Investigation Of Galena Biopharma Inc. - Yahoo FinanceGalena Biopharma Inc.  Plunges 9.19% on February 22 - Equities.com"
p8
aS'Galena Biopharma Inc.  Soars 6.78% on February 24 Equities.com - Feb 24, 2017 Galena Biopharma Inc.  had a good day on the market for Friday February 24 as shares jumped 6.78% to close at $0.69. About 1.85 million shares traded hands on 2,756 trades for the day, compared with an average daily volume of 1.63 million shares&nbsp;...'
p9
aS'Active Stock on Watch: Galena Biopharma Inc  Sherwood Daily - 21 hours ago Shares of Galena Biopharma Inc  is moving on volatility today 9.68% or $0.06 rom the open. The NASDAQ listed company saw a recent bid of 0.68 on 9352091 volume.'
p10
a.